What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Chemotherapy
His primary areas of investigation include Surgery, Internal medicine, Multiple myeloma, Transplantation and Chemotherapy.
His Surgery study deals with Aspergillosis intersecting with Lung, Respiratory disease and Amphotericin B.
Denis Caillot has researched Internal medicine in several fields, including Gastroenterology and Oncology.
His biological study spans a wide range of topics, including Hematopoietic stem cell transplantation and Pathology.
In his research on the topic of Multiple myeloma, Survival analysis is strongly related with Urology.
His studies deal with areas such as Myeloid leukemia and Maintenance therapy as well as Transplantation.
His most cited work include:
- Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis (2622 citations)
- Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma (890 citations)
- Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma (795 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Multiple myeloma, Surgery, Oncology and Transplantation.
Denis Caillot works mostly in the field of Internal medicine, limiting it down to topics relating to Gastroenterology and, in certain cases, Immunology.
His Multiple myeloma research is multidisciplinary, incorporating perspectives in Newly diagnosed and Dexamethasone.
He works mostly in the field of Surgery, limiting it down to concerns involving Aspergillosis and, occasionally, Mycosis.
His study looks at the relationship between Oncology and fields such as Myeloid leukemia, as well as how they intersect with chemical problems.
His Transplantation study combines topics in areas such as Retrospective cohort study and Bone marrow, Minimal residual disease.
He most often published in these fields:
- Internal medicine (65.96%)
- Multiple myeloma (43.07%)
- Surgery (33.73%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (65.96%)
- Oncology (32.53%)
- Multiple myeloma (43.07%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Oncology, Multiple myeloma, Newly diagnosed and Dexamethasone are his primary areas of study.
His research on Internal medicine often connects related areas such as Stem cell.
His work deals with themes such as Hematopoietic stem cell transplantation, Cyclophosphamide, Chemotherapy, Myeloid leukemia and Hazard ratio, which intersect with Oncology.
Many of his research projects under Multiple myeloma are closely connected to In patient with In patient, tying the diverse disciplines of science together.
His Autologous stem-cell transplantation research also works with subjects such as
- Extramedullary disease which connect with Novel agents,
- Incidence, which have a strong connection to Transplantation Conditioning, Surgery, Malignancy and Salvage therapy.
His Transplantation research incorporates elements of Cumulative incidence and Lymphoma.
Between 2017 and 2021, his most popular works were:
- Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study (261 citations)
- Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study (136 citations)
- Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial (83 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Chemotherapy
Denis Caillot mainly investigates Internal medicine, Multiple myeloma, Oncology, Transplantation and Thalidomide.
His Internal medicine study frequently draws connections to other fields, such as Gastroenterology.
His research in the fields of Bortezomib, Lenalidomide and Autologous stem-cell transplantation overlaps with other disciplines such as In patient and Text mining.
His work in Oncology tackles topics such as Gemtuzumab ozogamicin which are related to areas like Chemotherapy regimen.
His studies in Transplantation integrate themes in fields like Positron emission tomography, Newly diagnosed, Standard technique and Blood pool.
His Pomalidomide study in the realm of Thalidomide connects with subjects such as Standard treatment.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
